logo
logo
  • What we do
    • Strategic and Tactical Competitive Insights
    • Digital Health, Artificial Intelligence & Internet of Everything
    • Gene & Cell Therapy and Rare Diseases’ Research
    • Vaccines & Infectious Diseases Research
    • Investment Insights
  • News
  • Insights
  • Our work
  • LucidSearch
  • QuickAnswers
  • Contact Us
  • Search

case study

LucidQuest Our Work Competitive Intelligence

How we allayed a major pharma΄s concerns about Gx entrants and supported unbiased decision-making in the EU market. 

The challenge: Estimating the threat of existing and potential generic…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

How we helped a mid-size Pharma delve into the competitor landscape and support its brand strategy development.

The challenge: Βuilding an up-to-date biosimilar competitor landscape.  A…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

How we helped a mid-size pharma prepare its sales (SF) and medical teams (MSL) for a competitor's new launch in the migraine prevention space.

The Challenge: Knowing your competitor's new asset market entry timelines.…


by LucidQuest

LucidQuest Case Study Oncology

How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts.

The Challenge: Mapping prostate cancer stage and identifying key stakeholders…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

A major pharma in the COPD / Asthma space strengthened its market position due to competitive intelligence obtained through conference coverage.

The Challenge: Gathering competitive intelligence at conferences Α major…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

How we helped a major pharma identify and monitor existing and new Gx EU competitors and settle specific court actions with few of them.

The challenge: Identifying and monitoring current and potential competitors and…


by LucidQuest

LucidQuest Our Work Competitive Intelligence

How we helped a specialty respiratory company understand the "trends" of severe asthma and COPD assets and position itself strategically.

The Challenge: Staying updated with emerging trends in the respiratory market…


by LucidQuest

LucidQuest Case Study Oncology

How a large pharma in the EU oncology space gained and used competitive intelligence to craft a defense against threats from generics.

The Challenge: Gaining Competitive Intelligence on upcoming generics…


by LucidQuest

LucidQuest Case Study Oncology

How we helped two pharma companies assess their own and their competitors' social media during ESMO 2023 and ASCO 2023.

The Challenge: How to maximize the benefits of social media monitoring during…


by LucidQuest

LucidQuest Case Study Hematology

How our benchmarking analysis contributed to a Hemato-Oncology company's sales and pricing strategy for specific agents.

The Challenge: Competitive benchmarking, including sales force and market…


by LucidQuest

LucidQuest Case Study Hematology

How a hematology brand utilized competitor sales force research to defend itself against a competitor entrant in Spain.

The Challenge: How to react to a new entrant threat A hematology brand team of…


by LucidQuest

LucidQuest Case Study Hematology

How a pharma in the multiple myeloma space gained access to leading KOLs insights and used them in its asset development process.

The Challenge: Understanding how KOLs define the treatment evolution and the…


by LucidQuest

Categories

  • Insights
  • Case studies
  • News

Recent Posts

  • Public Health Weekly News – June 13th 2025
  • Respiratory Weekly News – June 13th 2025
  • Vaccines Weekly Update – June 13th 2025
  • Cell and Gene Therapy Weekly News – June 12th 2025
  • Rare Diseases Weekly News – June 12th 2025

Tags

advanced therapies antimicrobial resistance bioinformatics biosimilar drugs cancer co-pilot complex innovative design corporate venture capital dostarlimab Elranatamab ESMO 2021 Galderma GDM gene editing gene therapy approval Glioblastoma GLP1 updates Healthcare Innovation hematology hpv HPV Vaccine kidney disease lung cancer MigraineTreatment MPS IIIB mRNA technology MSA NFTs in healthcare non viral vectors Norovirus Omada health pediatric health pharma Progressive Supranuclear Palsy pulmonary care rare disease RSV Prevention SCLC Sema4 Smart Health SpringWorks stroke recovery T2D vaccine distribution οur work

Archives

  • 1
  • 2
  • 3
  • 4
LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

  • Public Health Weekly News – June 13th 2025
  • Respiratory Weekly News – June 13th 2025
  • Vaccines Weekly Update – June 13th 2025
  • Cell and Gene Therapy Weekly News – June 12th 2025
  • Rare Diseases Weekly News – June 12th 2025

TAGS

advanced therapies antimicrobial resistance bioinformatics biosimilar drugs cancer co-pilot complex innovative design corporate venture capital dostarlimab Elranatamab ESMO 2021 Galderma GDM gene editing gene therapy approval Glioblastoma GLP1 updates Healthcare Innovation hematology hpv HPV Vaccine kidney disease lung cancer MigraineTreatment MPS IIIB mRNA technology MSA NFTs in healthcare non viral vectors Norovirus Omada health pediatric health pharma Progressive Supranuclear Palsy pulmonary care rare disease RSV Prevention SCLC Sema4 Smart Health SpringWorks stroke recovery T2D vaccine distribution οur work
  • What we do
    • Strategic and Tactical Competitive Insights
    • Digital Health, Artificial Intelligence & Internet of Everything
    • Gene & Cell Therapy and Rare Diseases’ Research
    • Vaccines & Infectious Diseases Research
    • Investment Insights
  • News
  • Insights
  • Our work
  • LucidSearch
  • QuickAnswers
© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.
Privacy Policy